Charles River Laboratories International, Inc. Share Price
Equities
CRL
US1598641074
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
232.8 USD | +1.93% | -1.47% | -1.51% |
Sales 2024 * | 4.22B 335B | Sales 2025 * | 4.53B 359B | Capitalization | 11.99B 952B |
---|---|---|---|---|---|
Net income 2024 * | 406M 32.23B | Net income 2025 * | 513M 40.72B | EV / Sales 2024 * | 3.3 x |
Net Debt 2024 * | 1.94B 154B | Net Debt 2025 * | 1.46B 116B | EV / Sales 2025 * | 2.97 x |
P/E ratio 2024 * |
29.4
x | P/E ratio 2025 * |
23.8
x | Employees | 21,100 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.11% |
Latest transcript on Charles River Laboratories International, Inc.
1 day | +1.93% | ||
1 week | -1.47% | ||
Current month | +1.67% | ||
1 month | -3.53% | ||
3 months | -5.02% | ||
6 months | +30.53% | ||
Current year | -1.51% |
Managers | Title | Age | Since |
---|---|---|---|
James Foster
CEO | Chief Executive Officer | 73 | 31/12/75 |
Flavia Pease
DFI | Director of Finance/CFO | 51 | 24/04/22 |
Birgit Girshick
COO | Chief Operating Officer | 54 | 31/03/89 |
Members of the board | Title | Age | Since |
---|---|---|---|
George Massaro
BRD | Director/Board Member | 76 | 31/12/02 |
Virginia Wilson
BRD | Director/Board Member | 68 | 30/09/19 |
Robert Bertolini
BRD | Director/Board Member | 61 | 24/01/11 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
3.05% | 1 M€ | -2.17% | - | |
2.07% | 5 M€ | -1.80% | - | |
1.08% | 0 M€ | 0.00% | - | |
0.98% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
14/05/24 | 232.8 | +1.93% | 502,307 |
13/05/24 | 228.4 | +0.13% | 447,273 |
10/05/24 | 228.1 | -0.86% | 842,499 |
09/05/24 | 230.1 | -2.21% | 1,004,419 |
08/05/24 | 235.3 | -0.43% | 610,321 |
Delayed Quote Nyse, May 14, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.51% | 11.99B | |
+29.03% | 49.18B | |
-0.10% | 42.11B | |
+43.45% | 40.37B | |
-5.26% | 28.85B | |
+11.48% | 26.09B | |
-22.74% | 18.71B | |
+9.06% | 13.26B | |
+30.01% | 12.32B | |
+22.69% | 11.97B |
- Stock Market
- Equities
- CRL Stock